BioTech/Drugs - San Diego, CA, US
Aspen is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical need, beginning with autologous neuron replacement for both sporadic and genetic forms of Parkinson's disease (PD) and extending across the brain and affected organs.
Outlook
Nginx
WordPress.org
Gravity Forms
Typekit
Google Cloud Hosting